tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

DiaMedica Therapeutics Inc

DMAC
Add to Watchlist
6.735USD
-0.085-1.25%
Close 07-24 16:00（ET）Quotes delayed by 15 min
362.90MMarket Cap
LossP/E TTM

DiaMedica Therapeutics Inc

6.735
-0.085-1.25%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

DMAC Financials

See DiaMedica Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

DiaMedica Therapeutics Inc Earnings Date

Latest Release
May 6, 2026
EPS / Forecast
-0.19/-0.19
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.70
-15.28%
Analyst Rating
BUY
2026/07/26
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-3.77%-0.19
9.65%-0.17
-15.84%-0.17
-33.28%-0.18
-32.56%-0.18
-35.93%-0.18
-24.56%-0.15
17.97%-0.13
31.92%-0.14
4.29%-0.14
---0.12
---0.16
---0.20
---0.14
----
----
----
----
----
----
Net Profit
-30.30%-10.04M
-10.63%-8.74M
----
-50.40%-7.70M
-49.62%-7.71M
-53.07%-7.90M
-40.33%-6.27M
-14.34%-5.12M
2.30%-5.15M
-37.59%-5.16M
-46.16%-4.47M
-33.32%-4.48M
-50.29%-5.27M
-15.56%-3.75M
11.33%-3.06M
---3.36M
3.15%-3.51M
22.71%-3.25M
-8.05%-3.45M
----
Debt to assets ratio
-60.10%0.02%
-54.69%0.02%
-44.10%0.03%
16.41%0.06%
830.38%0.06%
629.91%0.05%
519.88%0.05%
383.95%0.05%
-79.55%0.01%
-74.58%0.01%
--0.01%
--0.01%
--0.03%
--0.03%
----
----
----
----
----
----
Income Statement
Operating profit
-28.71%-10.48M
-9.43%-9.21M
-31.24%-9.03M
-42.02%-8.01M
-41.86%-8.14M
-43.96%-8.42M
-33.47%-6.88M
-18.92%-5.64M
-3.98%-5.74M
-47.19%-5.85M
-64.87%-5.16M
-40.93%-4.74M
-56.14%-5.52M
-22.40%-3.97M
8.43%-3.13M
---3.36M
2.29%-3.54M
23.95%-3.25M
-3.70%-3.42M
----
Net Profit
-30.30%-10.04M
-10.63%-8.74M
----
-50.40%-7.70M
-49.62%-7.71M
-53.07%-7.90M
-40.33%-6.27M
-14.34%-5.12M
2.30%-5.15M
-37.59%-5.16M
-46.16%-4.47M
-33.32%-4.48M
-50.29%-5.27M
-15.56%-3.75M
11.33%-3.06M
---3.36M
3.15%-3.51M
22.71%-3.25M
-8.05%-3.45M
----
Balance Sheet
Current assets
39.93%52.36M
35.91%60.63M
10.75%56.22M
-43.51%31.08M
-21.19%37.42M
-16.89%44.61M
6.02%50.77M
33.43%55.01M
60.02%47.48M
58.64%53.67M
31.23%47.89M
5.25%41.23M
-29.53%29.67M
-25.54%33.84M
-24.82%36.49M
81.11%39.17M
74.05%42.11M
62.74%45.44M
56.04%48.54M
74.44%21.63M
Total current liabilities
23.22%5.75M
-4.79%5.13M
22.60%5.27M
33.29%4.12M
78.26%4.67M
93.47%5.39M
98.02%4.30M
58.68%3.09M
-7.00%2.62M
28.51%2.79M
40.73%2.17M
26.69%1.95M
96.23%2.81M
42.26%2.17M
-5.05%1.54M
6.67%1.54M
21.73%1.43M
-24.85%1.52M
12.54%1.62M
18.32%1.44M
Total assets
36.70%53.08M
32.42%61.37M
8.61%57.05M
-44.59%31.47M
-21.17%38.83M
-14.43%46.34M
-9.66%52.52M
-8.48%56.79M
63.02%49.26M
57.46%54.16M
56.96%58.14M
58.06%62.05M
-28.41%30.22M
-24.49%34.40M
-23.88%37.04M
80.30%39.26M
73.31%42.21M
62.13%45.55M
55.63%48.66M
73.07%21.77M
Total liabilities
19.87%5.84M
-6.52%5.26M
18.97%5.42M
27.37%4.30M
67.50%4.88M
81.34%5.63M
81.67%4.56M
46.34%3.38M
-8.89%2.91M
20.83%3.10M
27.93%2.51M
49.51%2.31M
121.41%3.19M
68.17%2.57M
20.52%1.96M
5.98%1.54M
19.16%1.44M
-26.62%1.53M
7.67%1.63M
11.23%1.46M
Total equity
39.11%47.23M
37.80%56.11M
7.63%51.62M
-49.13%27.17M
-26.74%33.95M
-20.25%40.72M
-13.78%47.96M
-10.59%53.41M
71.52%46.35M
60.42%51.06M
58.58%55.63M
58.41%59.74M
-33.72%27.02M
-27.71%31.83M
-25.42%35.08M
85.62%37.72M
76.14%40.77M
69.23%44.02M
58.06%47.04M
80.25%20.32M
Cash Flow Statement
Net operating income
-27.04%-9.08M
-20.69%-7.76M
-515.79%-27.53M
-68.13%-7.60M
-7.46%-7.15M
-68.78%-6.43M
6.82%-4.47M
10.16%-4.52M
-30.73%-6.65M
-37.82%-3.81M
-103.18%-4.80M
-101.52%-5.03M
-30.89%-5.09M
1.36%-2.77M
22.49%-2.36M
-19.48%-2.50M
9.85%-3.89M
7.03%-2.80M
-29.78%-3.05M
-147.51%-2.09M
Net investment
-131.92%-2.11M
53.60%8.00M
3.46%-5.39M
89.13%8.96M
57.37%6.62M
-15.01%5.21M
-566.97%-5.58M
116.84%4.74M
67.72%4.21M
29.64%6.12M
-42.28%1.20M
-1212.66%-28.13M
13.32%2.51M
154.37%4.72M
116.15%2.07M
155.61%2.53M
24700.00%2.21M
-1402.70%-8.69M
8.37%-12.83M
-60.44%989.00K
Net financing
358.24%417.00K
9975.83%12.09M
25536.59%31.53M
-98.63%161.00K
9200.00%91.00K
12100.00%120.00K
2150.00%123.00K
-68.11%11.75M
0.00%-1.00K
0.00%-1.00K
-200.00%-6.00K
1842600.00%36.85M
0.00%-1.00K
94.74%-1.00K
-100.01%-2.00K
-100.00%-2.00K
-100.41%-1.00K
51.28%-19.00K
40.95%29.86M
0.00%-1.00K

FAQs

What are the current assets of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its current assets were 60.63M, with a year-on-year change of 35.91.

What are the total assets of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its total assets of DiaMedica Therapeutics Inc were 61.37M, with a year-on-year change of 32.42.

What are the total liabilities of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its total liabilities of DiaMedica Therapeutics Inc were 5.26M, with a year-on-year change of -6.52.

What is the total equity of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its total equity of DiaMedica Therapeutics Inc was 56.11M, with a year-on-year change of 37.80.

What is the net operating income of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its net operating income of DiaMedica Therapeutics Inc was -34.40M, with a year-on-year change of -28.92.

What is the net investment of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its net investment of DiaMedica Therapeutics Inc was -2.19M, with a year-on-year change of -125.60.

What is the net financing of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its net financing of DiaMedica Therapeutics Inc was 43.88M, with a year-on-year change of 265.82.

What is the Earnings Per Share (EPS) of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.70, with a year-on-year change of -15.28.

What is the net income of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its net income was -32.77M, with a year-on-year change of -34.05.

What is the debt-to-asset ratio of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.02, with a year-on-year change of -54.69.

What is the Return on Equity (ROE) of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -67.68, with a year-on-year change of -27.05.

What is the Return on Assets (ROA) of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -60.84, with a year-on-year change of -25.07.

What is the operating profit of DiaMedica Therapeutics Inc?

According to DiaMedica Therapeutics Inc's FY2025 earnings report, its operating profit was -34.40M, with a year-on-year change of -28.92.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy